Citigroup Portfolio holdings
Citigroup is a multinational investment bank and financial services company, formed in 1998 when Citicorp, the holding company for Citibank, merged with Travelers. Citibank dates to 1812, when it was chartered as City Bank of New York to serve a group of local merchants. In 2009 it merged its Smith Barney brokerage and wealth unit with Morgan Stanley's into a joint venture, and in 2013 it sold its remaining stake to Morgan Stanley. Its businesses cover investment, corporate and commercial banking, sales and trading in the markets, cash management and trade finance for companies, wealth management, and credit cards in the United States.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.36B |
| 2 |
Tesla
TSLA
|
+$1.09B |
| 3 |
Amazon
AMZN
|
+$1B |
| 4 |
Microsoft
MSFT
|
+$963M |
| 5 |
Apple
AAPL
|
+$864M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.22B |
| 2 |
Bank of America
BAC
|
+$1.2B |
| 3 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$381M |
| 4 |
First Trust Dow Jones Internet Index Fund ETF
FDN
|
+$294M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 39.44% |
| 2 | Technology | 25.75% |
| 3 | Financials | 6.27% |
| 4 | Consumer Discretionary | 5.79% |
| 5 | Industrials | 5.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4601
Motorcar Parts of America
MPAA
$195M
| $92.3K | ﹤0.01% |
6,025
+5,402
| +867% | +$65.4K |
2023 Q2
12 quarters
|
|
4602
The Elmet Group
ELMT
$706M
| $92.3K | ﹤0.01% |
+4,674
| New | +$80.3K |
2026 Q2
0 quarters
|
|
4603
Protara Therapeutics
TARA
$147M
| $92.2K | ﹤0.01% |
24,145
+9,669
| +67% | +$46K |
2024 Q4
6 quarters
|
|
4604
SOLV Energy Inc
MWH
$4.71B
| $91.8K | ﹤0.01% |
+2,697
| New | +$97.8K |
2026 Q2
0 quarters
|
|
4605
Eaton Vance Tax-Managed Global Diversified Equity Income Fund
EXG
$2.86B
| $91.8K | ﹤0.01% |
9,360
+62
| +0.7% | +$581 |
2013 Q2
52 quarters
|
|
4606
BRC Group Holdings
RILY
$163M
| $91.7K | ﹤0.01% |
11,403
+9,735
| +584% | +$82.8K |
2016 Q2
40 quarters
|
|
4607
Core Molding Technologies
CMT
$198M
| $91.5K | ﹤0.01% |
3,877
+3,499
| +926% | +$86K |
2023 Q2
12 quarters
|
|
4608
Eagle Financial Services Inc
EFSI
$247M
| $91.3K | ﹤0.01% |
2,202
+1,988
| +929% | +$77.9K |
2025 Q2
4 quarters
|
|
4609
Lifeway Foods
LWAY
$346M
| $90.5K | ﹤0.01% |
3,033
+2,350
| +344% | +$59.8K |
2023 Q3
11 quarters
|
|
4610
Foghorn Therapeutics
FHTX
$124M
| $90.5K | ﹤0.01% |
18,544
+15,129
| +443% | +$67.1K |
2020 Q4
22 quarters
|
|
4611
ProFrac Holding
ACDC
$889M
| $90.4K | ﹤0.01% |
15,558
+5,976
| +62% | +$40.3K |
2022 Q2
16 quarters
|
|
4612
Coherus Oncology
CHRS
$128M
| $90.1K | ﹤0.01% |
64,342
+12,009
| +23% | +$19.6K |
2014 Q4
46 quarters
|
|
4613
Peoples Bancorp of North Carolina
PEBK
$234M
| $89.9K | ﹤0.01% |
2,087
+1,891
| +965% | +$78.5K |
2023 Q4
10 quarters
|
|
4614
Atrium Therapeutics
RNA
$141M
| $89.9K | ﹤0.01% |
6,685
+6,047
| +948% | +$79K |
2026 Q1
1 quarter
|
|
4615
Voyager Therapeutics
VYGR
$106M
| $89.9K | ﹤0.01% |
25,680
+21,811
| +564% | +$82.7K |
2022 Q3
15 quarters
|
|
4616
Bullish
BLSH
$3.62B
| $89.9K | ﹤0.01% |
3,835
-6,121
| -61% | -$213K |
2025 Q3
3 quarters
|
|
4617
Surrozen
SRZN
$341M
| $89.7K | ﹤0.01% |
+3,455
| New | +$94.9K |
2026 Q2
0 quarters
|
|
4618
Meridian
MRBK
$223M
| $89.6K | ﹤0.01% |
4,475
+4,035
| +917% | +$76.5K |
2023 Q4
10 quarters
|
|
4619
Princeton Bancorp
BPRN
$293M
| $89.3K | ﹤0.01% |
2,354
+2,107
| +853% | +$75.4K |
2022 Q4
14 quarters
|
|
4620
Neumora Therapeutics
NMRA
$69M
| $89.3K | ﹤0.01% |
52,503
+3,710
| +8% | +$7.06K |
2023 Q3
11 quarters
|
|
4621
Bombardier Recreational Products
DOO
$4.35B
| $89.1K | ﹤0.01% |
1,460
-555
| -28% | -$33.4K |
2021 Q2
20 quarters
|
|
4622
CALL
Lyft
LYFT
$6.12B
| $89.1K | ﹤0.01% |
6,100
-335,000
| -98% | -$4.68M |
2025 Q4
2 quarters
|
|
4623
Taylor Devices
TAYD
$181M
| $89K | ﹤0.01% |
1,517
+578
| +62% | +$31.3K |
2025 Q4
2 quarters
|
|
4624
KORU Medical Systems
KRMD
$138M
| $88.8K | ﹤0.01% |
21,138
+18,847
| +823% | +$77.2K |
2023 Q2
12 quarters
|
|
4625
RxSight
RXST
$203M
| $88.7K | ﹤0.01% |
18,398
+16,349
| +798% | +$98.7K |
2021 Q3
19 quarters
|
|
Similar funds
Citigroup's Q2 2026 Portfolio in Review
As of Q2 2026, Citigroup held 6,442 positions worth $303B, up 29% from $235B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Citigroup deployed $27.6B of net new capital in Q2 2026, opening 555 new positions and adding to 3,283 existing holdings. Its largest new stake was Honeywell Aerospace: 579,875 shares worth $128M.
By sector, the portfolio is most concentrated in Miscellaneous at 39% of assets, down from 45% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $1.22B trimmed.
- Citigroup's largest Q2 2026 buy was Honeywell Aerospace: 579,875 shares worth $128M.
- Citigroup added most to NVIDIA in Q2 2026, an estimated $2.36B increase.
- Citigroup's biggest Q2 2026 reduction was iShares Russell 2000 ETF, cutting an estimated $1.22B.
- Citigroup fully exited Sealed Air in Q2 2026, selling an estimated $111M.
- Citigroup's ten largest holdings make up 20% of its $303B portfolio in Q2 2026.
- Citigroup opened 555 new positions and closed 760 in Q2 2026.
- Citigroup's portfolio value rose 29% quarter-over-quarter to $303B.
Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.